Inventurus Knowledge Solutions Limited · NSE:IKS
Inventurus Knowledge Solutions — Q2 FY27 Earnings Presentation
19 slides from Inventurus Knowledge Solutions's earnings presentation, Nov 5, 2026
Slide 1: Exchange filing cover letter
------------------------------------------------------------------------------------------------------------------------------------------------ November 5, 2026 BSE Limited National Stock Exchange of India Limited The Listing Department The Listing Department Phiroze Jeejeebhoy Towers Exchange Plaz
Slide 2: IKS Health Q2 FY27 Investor Presentation
IKS Health Q2 FY 27 Investor Presentation 1
Slide 3: Disclaimer
Disclaimer This presentation may include opinions and assumptions about future performance which could be considered as forward-looking statements. Forward-looking statements intrinsically cover several risks and uncertainties, which may lead to a material difference between actual results and the s
Slide 4: IKS Health - a comprehensive healthcare enablement platform
IKS Health - a comprehensive healthcare enablement platform empowering provider organizations US$260bn / US$5tn US$34bn 8% / 12% Total US Healthcare TAM / Outsourced Market TAM / Outsourced Market Addressable Expenditure (CY 2024) (CY 2023) CAGR (2023-2028E) Market1,2 The only Comprehensive platform
Slide 5: IKS Health: strategic pillars of execution
IKS Health: 5 strategic pillars of execution Integrated System of Action Proprietary models driven Drive growth momentum Get back to optimized Culture and leadership (SOA) & System of Record comprehensive System of through re-stratified key margins through operating (SOR) for rural/ community Action
Slide 6: Building a System of Intelligence
Building a System of Intelligence Powering the System of Record and the System of Action EHR (System of Record) IKS Platform (System of Action) ● Data repository ● Dynamic, real-time impact ● Single source of truth ● Workflow optimization & automation ● HITL for safety, oversight, System of Intellig
Slide 7: Two paths to AI transformation
Two paths to AI transformation Meeting organizations where they are to protect existing EHR investments while collapsing layers into one AI-native platform for new segments like rural health. Future operating system Build on existing architecture AI-native platform Sits on top of existing EHR infras
Slide 8: IKS Health enables care transformation across the patient journey
IKS Health enables care transformation across the patient journey Pre-visit Optimized Patient Financial Patient Engagement Prospective Clinical Scheduling Clearance Hub Chart Reviews Peri-visit Autonomous Coding Referral Order Management IKS ScribbleTM Pre-Visit Summary Legend Automation Level Post-
Slide 9: Bringing innovation at scale to TruBridge clients
Bringing innovation at scale to TruBridge clients Initial areas of focus Claims Denials Coding Clinical Efficiency Denial prediction & optimization End-to-end coding suite Virtual care assistant + Scribble Uses AI to identify denial risk before AI-assisted coding with human validation and Automates
Slide 10: Key deal wins
Key deal wins Comprehensive RCM optimization partnership with White-Wilson Medical Center in Northwest Florida, a large multi-specialty group providing primary, specialty, imaging, and lab care. The partnership spans end-to-end RCM and scheduling, establishing IKS Health as a growth partner to scale
Slide 11: Q2 FY 27: Consolidation of TruBridge (82 Days)
Q2 FY 27: Consolidation of TruBridge (82 Days) Deep Client Strong Margin Globally Diversified Growth At Scale Relationships Profile Workforce 450+ 28% 16,318 INR 15,925 mn Enterprise level EBITDA Total Employees Revenue from customers Operations 103.9% INR mn 3,418 29% 2,226 / 750 YoY growth in INR
Slide 12: Q2 FY 27: Revenue and EBITDA
Q2 FY 27: Consolidation of TruBridge (82 Days) Revenue INR Mn 15,925 103.9% YoY 7,811 8,936 78.2% QoQ Q2 FY26 Q1 FY27 Q2 FY27 EBITDA Adjusted EBITDA* INR Mn INR Mn 4,415 4,591 2,949 62.5% YoY 2,718 63.2% YoY 3,167 2,814 27.7% 33.0% 28.8% 34.8% 49.7% QoQ 35.4% 45.0% QoQ 36% Q2 FY26 Q1 FY27 Q2 FY27 Q2
Slide 13: Q2 FY 27: PBT and PAT
Q2 FY 27: Consolidation of TruBridge (82 Days) PBT INR Mn 2,732 2,563 2,291 19.2% YoY 17.2% 35.4% 36.0% 6.6% QoQ Q2 FY26 Q1 FY27 Q2 FY27 PAT Adjusted PAT* INR Mn INR Mn 2,734 2,176 1,807 1,937 20.4% YoY 2,265 36.0% YoY 2,011 13.7% 17.2% 21.7% 25.3% 23.1% 12.3% QoQ 20.7% QoQ 25.7% Q2 FY26 Q1 FY27 Q2
Slide 14: Q2 FY 27: Continued strong cash generation
Q2 FY 27: Continued strong cash generation OCF & FCF Net Debt INR Mn INR Mn 35.4% OCF YoY 16.6% FCF YoY Cash flow has been adjusted for acquisition expenses incurred by Trubridge for which liability was acquired upon acquisition but paid post acquisition and is impacting quarterly cash flow to the e
Slide 15: Q2 FY 27 - Improving EPS and maintaining high ROE
Q2 FY 27 - Improving EPS and maintaining high ROE EPS ₹ ROE %* 34.4% 13.0 11.6 26.4% 27.2% 10.8 20.1% YoY 12.3% QoQ Q2 FY26 Q1 FY27 Q2 FY27 Q2 FY26 Q1 FY27 Q2 FY27 EPS is calculated as profit for the period divided by weighted Return on Equity is calculated as profit for the period divided average n
Slide 16: Financials - Summary INR millions
Financials - Summary INR millions INR Mn Particulars Q2 FY 27 Q1 FY 27 QoQ% Q2 FY 26 YoY% H1 FY 27 H1 FY 26 YoY% Revenue USD mn 169 97 73.9% 90 87.3% 266 177 50.4% Revenue 15,925 8,936 78.2% 7,811 103.9% 24,861 15,212 63.4% Forex Gain/ (Loss) 86 12 619.9% 177 -51.5% 98 188 -48.2% Employee benefit ex
Slide 17: Other KPI Metrics
Other KPI Metrics Particulars Q2 FY 27 Q1 FY 27 Q2 FY 26 Annualised Adjusted EBITDA per employee in INR mn 1.29 0.99 0.91 Revenue from Top 10 customers INR mn 3,418 4,808 3,548 Contribution from Top 10 customers 21.5% 53.8% 45.4% Revenue from Top 5 customers INR mn 2,426 3,759 2,628 Contribution fro
Slide 18: A decade of consistent profitable growth
A decade of consistent profitable growth 28.7% 46.4% 15% Revenue CAGR PAT CAGR Headcount CAGR 17
Slide 19: Thank You
Thank You HEALTH
Inventurus Knowledge Solutions — Q2 FY27 Earnings Presentation on 6ix